Influence of Gender and Reproductive Factors on Liver Fibrosis in Patients With Chronic Hepatitis B Infection
| Autor: | Qiaoping Wu, Fansen Zeng, Ronglong Jiang, Weiqun Wen, Ming Xiong, Yali Ji, Jiang Liu, Jinjun Chen, Shuling Yang, Jinlin Hou, Qingjun He, Fuyuan Zhou, Junying Li |
|---|---|
| Rok vydání: | 2019 |
| Předmět: |
Adult
Liver Cirrhosis Male medicine.medical_specialty Adolescent Biopsy Logistic regression Gastroenterology Article Young Adult Hepatitis B Chronic Sex Factors Fibrosis Internal medicine medicine Humans Longitudinal Studies Prospective Studies Stage (cooking) Prospective cohort study Reproductive History Aged Aged 80 and over Menarche business.industry Age Factors Odds ratio Middle Aged medicine.disease Postmenopause Menopause Cross-Sectional Studies Liver ROC Curve Disease Progression Elasticity Imaging Techniques Female Transient elastography business |
| Zdroj: | Clinical and Translational Gastroenterology |
| ISSN: | 2155-384X |
| DOI: | 10.14309/ctg.0000000000000085 |
| Popis: | INTRODUCTION: The role of reproductive factors in the development of chronic hepatitis B (CHB) remains unknown. We assessed the potential contributions of gender, menopausal status, and menarche age to liver fibrosis in CHB. METHODS: A cross-sectional prospective study included 716 women and 716 age-matched men with CHB who were not currently receiving antiviral therapy. Liver stiffness measurement using transient elastography was used to stage liver fibrosis as F0–F1 (14 years compared with 0.05). Longitudinal data analysis showed that postmenopausal women (n = 31) were significantly less likely to undergo regression of liver fibrosis after antiviral treatment vs premenopausal women (n = 19) (26.3% vs 74.2%, respectively; P < 0.001). DISCUSSION: Menopause and late menarche aggravated liver fibrosis in untreated CHB, besides menopause delayed fibrosis regression under antiviral therapy. The protective effect of female gender against fibrosis was lost for postmenopausal women. TRANSLATIONAL IMPACT: It is important to consider menopausal status and age at menarche in establishing surveillance strategies among CHB females. Postmenopausal estrogen therapy may be considered for the prevention or treatment of liver fibrosis. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|